Unlike CRISPR, which edits DNA by cutting and altering sequences, VECTOR focuses on repositioning genes without modifying their sequences. This approach could help regulate protein imbalances ...
In October 2024, the companies announced a second collaboration agreement providing Roche with further access to Dyno’s field-leading platform and sequence design methods for the treatment of ...